What does CUSIP 65343E108 represent in this 13F holders report?

CUSIP 65343E108 is the security identifier for NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

How many institutions held NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share in Q2 2021?

74 institutional investors reported NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share for Q2 2021. Use the holders table for investor-level position and value details.

NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC)

CUSIP: 65343E108

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 3,602,511
Total 13F shares: 15,461,583
Share change: -2,496,801
Total reported value: $124,156,911
Put/Call ratio: 60%
Price per share: $8.03
Number of holders: 74
Value change: -$24,114,984
Number of buys: 33
Number of sells: 60

Quarterly Holders Quick Answers

What is CUSIP 65343E108?
CUSIP 65343E108 identifies NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 65343E108:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	75%	2,711,013	$27,137,000	—	31 Mar 2021	13F
Sofinnova Investments, Inc.	13F	Company	74%	2,671,856	$26,745,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	60%	2,158,166	$21,602,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	29%	1,060,418	$10,614,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	27%	978,240	$9,792,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	23%	844,283	$8,452,000	—	31 Mar 2021	13F
Canaan Partners X LLC	13F	Company	23%	838,442	$8,393,000	—	31 Mar 2021	13F
HHLR ADVISORS, LTD.	13F	Company	16%	563,907	$5,645,000	—	31 Mar 2021	13F
Ikarian Capital, LLC	13F	Company	13%	453,952	$4,544,000	—	31 Mar 2021	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	12%	449,208	$4,497,000	—	31 Mar 2021	13F
SG Americas Securities, LLC	13F	Company	8.9%	319,939	$3,203,000	—	31 Mar 2021	13F
Lion Point Capital, LP	13F	Company	8.3%	300,000	$3,003,000	—	31 Mar 2021	13F
Lombard Odier Asset Management (Switzerland) SA	13F	Company	7.7%	278,616	$2,789,000	—	31 Mar 2021	13F
Lombard Odier SCmA Compagnie	13F	Individual	7.7%	278,616	$2,789,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	7.6%	274,279	$2,746,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	6.9%	250,334	$2,505,000	—	31 Mar 2021	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	6.9%	248,500	$2,487,000	—	31 Mar 2021	13F
ArrowMark Colorado Holdings LLC	13F	Company	6.4%	228,855	$2,291,000	—	31 Mar 2021	13F
NORGES BANK	13F	Company	6.1%	219,254	$2,195,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	6%	215,000	$2,152,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	5.2%	186,023	$1,863,000	—	31 Mar 2021	13F
Marshall Wace North America L.P.	13F	Company	4.5%	163,278	$1,635,000	—	31 Mar 2021	13F
MACQUARIE GROUP LTD	13F	Company	4.2%	150,239	$1,504,000	—	31 Mar 2021	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	4.2%	150,000	$1,502,000	—	31 Mar 2021	13F
GSA CAPITAL PARTNERS LLP	13F	Company	4%	142,779	$1,429,000	—	31 Mar 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	3.2%	113,800	$1,139,000	—	31 Mar 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	3.1%	112,142	$1,125,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	2.7%	98,088	$982,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	2.5%	90,094	$902,000	—	31 Mar 2021	13F
NOMURA HOLDINGS INC	13F	Company	2.2%	78,620	$797,000	—	31 Mar 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	2.2%	79,457	$795,000	—	31 Mar 2021	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	2.1%	77,006	$771,000	—	31 Mar 2021	13F
PDT Partners, LLC	13F	Company	1.9%	66,922	$670,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	1.8%	66,544	$666,000	—	31 Mar 2021	13F
DAFNA Capital Management LLC	13F	Company	1.8%	65,000	$651,000	—	31 Mar 2021	13F
DEUTSCHE BANK AG\	13F	Company	1.6%	56,393	$565,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	1.6%	56,010	$560,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.4%	52,072	$522,000	—	31 Mar 2021	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	1.4%	51,689	$517,000	—	31 Mar 2021	13F
MARSHALL WACE, LLP	13F	Company	1.4%	49,558	$496,000	—	31 Mar 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	1.2%	44,352	$444,000	—	31 Mar 2021	13F
IndexIQ Advisors LLC	13F	Company	1.1%	40,913	$410,000	—	31 Mar 2021	13F
BARCLAYS PLC	13F	Company	1.1%	38,079	$381,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	1%	37,115	$372,000	—	31 Mar 2021	13F
HRT FINANCIAL LP	13F	Company	1%	37,070	$371,000	—	31 Mar 2021	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.98%	35,278	$354,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.92%	33,300	$333,000	—	31 Mar 2021	13F
Krensavage Asset Management, LLC	13F	Company	0.85%	30,603	$306,000	—	31 Mar 2021	13F
Swiss National Bank	13F	Company	0.77%	27,600	$276,000	—	31 Mar 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.71%	25,613	$256,000	—	31 Mar 2021	13F

Institutional Holders of NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC) as of Q2 2021

As of 30 Jun 2021, NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC) was held by 74 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,461,583 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Sofinnova Investments, Inc., BlackRock Inc., Canaan Partners X LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, MORGAN STANLEY, Ikarian Capital, LLC, FEDERATED HERMES, INC., and MILLENNIUM MANAGEMENT LLC. This page lists 74 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

-17

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.